You are here

Article info

Article menu
Download PDFPDF
Letter
Biologics, spondylitis and COVID-19

Authors

  1. Correspondence to Dr James Todd Rosenbaum, Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, USA; rosenbaj{at}ohsu.edu
View Full Text

Citation

Rosenbaum JT, Hamilton H, Choi D, et al
Biologics, spondylitis and COVID-19
Annals of the Rheumatic Diseases 2020;79:1663-1665.

Publication history

  • Received May 13, 2020
  • Revised May 21, 2020
  • Accepted May 22, 2020
  • First published June 10, 2020.
Online issue publication 
November 13, 2020

Article Versions

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage